Crossmark

Anti-neuropathic pain activity of a cationic palladium (II) dithiocarbamate by suppressing the inflammatory mediators in paclitaxel-induced neuropathic pain model

Crossref DOI link: https://doi.org/10.1007/s11033-021-06754-7

Published Online: 2021-11-03

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Naveed, Muhammad

Ullah, Rahim

Khan, Adnan

Shal, Bushra

Khan, Ashraf Ullah

Khan, Shahan Zeb

Rehman, Zia ur https://orcid.org/0000-0002-1436-3131
Khan, Salman https://orcid.org/0000-0001-7950-2983
Funding

Funding for this research was provided by:

Higher Education Commission, Pakistan (357 SRGP/HEC/2014)
License Information

Text and Data Mining valid from 2021-11-03

Version of Record valid from 2021-11-03
More Information

Article History

Received: 15 April 2021

Accepted: 10 September 2021

First Online: 3 November 2021

Declarations

:

: The authors declare they have no conflict of interest.

: “QAU guidelines for animal’s care” Islamabad were followed for the overall experiments involving animals. QAU, Islamabad Bioethical Committee (Approval No: BEC-FBS-QAU 2017–59) approved the study. Maximum care was assured to minimize harm to animals.

: N/A

Document is current

Any future updates will be listed below